Isentress
Product Images NDC 66336-214

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Isentress (NDC 66336-214). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0214-xx (Ndc 66336 0214 Xx Merck)

Ndc 66336-0214-xx (Ndc 66336 0214 Xx      Merck)
This is a detailed description of bulk source data regarding a medication distribution in tablet form named ISENTRESS 400 mg. Manufactured by Merck Sharp & Dohme Corp and distributed from Whitehouse Station, NJ 08889 in a bottle with a tight/light-resistant container, a label indicating tablet ID, NDC, pedigree#, lot#, rev. date, Rx#. Each tablet contains 434.4 mg Raltegravir Potassium equivalent to 400 mg Raltegravir. The product comes in a pink oval-shaped film-coated form with an inscription "227" on the surface. Patients are directed to take one tablet orally twice daily, swallow whole, and contact their doctor immediately if they develop rash. Patients may experience insomnia, headache, nausea, fatigue, or dizziness. The medicine must be kept out of children's reach and stored at a temperature between 68°- 77° F. This product is dispensed only with prescription RX#. There are different lots of this product with different manufacturing and expiration dates. This product is packaged exclusively by Dispensing Solution, Santa Ana, CA 92704.*
FDA Label Image

Image Of Raltegravir Potassium Chemical Structure (Isentress 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.